Postmenopausal Women With Luminal A Subtype May Not Require Breast Radiation Therapy - Results From a Randomized Clinical Trial of Tamoxifen ± Radiation

被引:0
|
作者
Fyles, T. W. [1 ]
Shi, W. [2 ]
Pintilie, M. [1 ]
Done, S. J. [3 ]
Miller, N. [1 ]
Weir, L. [4 ]
Olivotto, I. A. [5 ]
Trudeau, M. [6 ]
McCready, D. [1 ]
Liu, F. [1 ]
机构
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada
[3] Campbell Family Breast Canc Res Inst, Toronto, ON, Canada
[4] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[5] British Columbia Canc Agcy, Victoria, BC, Canada
[6] Odette Canc Ctr, Toronto, ON, Canada
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词
D O I
10.1016/j.ijrobp.2012.07.369
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S143 / S143
页数:1
相关论文
共 50 条
  • [41] Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study
    Bonneterre, J
    Thürlimann, B
    Robertson, JFR
    Krzakowski, M
    Mauriac, L
    Koralewski, P
    Vergote, I
    Webster, A
    Steinberg, M
    von Euler, M
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) : 3748 - 3757
  • [42] Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis
    Prema P. Peethambaram
    James N. Ingle
    Vera J. Suman
    Lynn C. Hartmann
    Charles L. Loprinzi
    Breast Cancer Research and Treatment, 1999, 54 : 117 - 122
  • [43] Randomized trial of two versus four years of adjuvant tamoxifen (AT) for postmenopausal women with node positive breast cancer
    Gallen, M
    Alonso, C
    Ojeda, B
    Viladiu, P
    Beltran, M
    Borras, J
    Pelegri, A
    Tusquets, I
    Barnadas, A
    Arcusa, A
    Bastus, R
    Balil, A
    Batiste-Alentorn, E
    Boleda, M
    Badia, MA
    Garau, I
    Guash, I
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S40 - S40
  • [44] Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis
    Peethambaram, PP
    Ingle, JN
    Suman, VJ
    Hartmann, LC
    Loprinzi, CL
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (02) : 117 - 122
  • [45] Adherence to Endocrine Therapy Predicts Short-Term Clinical Outcomes for Postmenopausal Women With Luminal B but Not Luminal A Breast Cancer
    Fahey, M.
    Mills, M. N.
    Liveringhouse, C.
    Ronica, N.
    Diaz, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E206 - E206
  • [46] Randomized trial of yoga in women with breast cancer undergoing radiation treatment.
    Cohen, L.
    Chandwani, K.
    Thornton, B.
    Perkins, G.
    Rivera, E.
    Arun, B.
    Raghuram, N.
    Nagendra, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 469S - 469S
  • [47] A RANDOMIZED CROSSOVER TRIAL COMPARING MEGESTROL-ACETATE WITH TAMOXIFEN AS INITIAL HORMONE-THERAPY FOR ADVANCED BREAST-CANCER IN POSTMENOPAUSAL WOMEN
    DANIEL, F
    TYRELL, CJ
    KEEN, CW
    SPOONER, D
    TAYLOR, AR
    TARRANT, J
    BLACKLEDGE, GRP
    STUART, NSA
    WEBSTER, DJT
    REES, FLG
    CLINICAL RADIOLOGY, 1988, 39 (06) : 686 - 686
  • [48] Updated results of a randomized trial of tamoxifen with or without radiation in women over 50 years of age with T1/2 N0 breast cancer
    Fyles, A.
    Manchul, L.
    McCready, D.
    Trudeau, M.
    Olivotto, I.
    Wier, L.
    Merante, M.
    Pintilie, M.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S1 - S1
  • [49] Gynaecological Assessment of Postmenopausal Women with an Asymptomatic Thickened Endometrium While on Tamoxifen: Results from a Double Blind Randomized Controlled Trial Comparing Continuation of Tamoxifen and Anastrozole
    Van Ginderachter, J.
    Vlasselaer, J.
    De Jonge, E.
    Berteloot, P.
    Depypere, H.
    Van den Broecke, R.
    Neven, P.
    Van Dam, P.
    Timmerman, D.
    Blomme, C.
    De Clercq, L.
    Van Calster, B.
    Vlaemynck, C.
    Amant, F.
    Vergote, I
    CANCER RESEARCH, 2009, 69 (24) : 737S - 737S
  • [50] Anastrozole is superior to tamoxifen in the treatment of postmenopausal women with early breast cancer - first results of the ATAC ('Arimidex', Tamoxifen, alone or in combination) trial
    Sainsbury, R
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 137 - 137